Cargando…
Preliminary results of a triple peptide escalating dose vaccination phase I/II clinical trial as consolidation treatment in women affected by ovarian cancer
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991372/ http://dx.doi.org/10.1186/2051-1426-1-S1-P227 |
| _version_ | 1782312425181151232 |
|---|---|
| author | Napoletano, Chiara Visconti, Valeria Antonilli, Morena Zizzari, Ilaria G Rahimi, Hassan Battisti, Federico Caponnetto, Salvatore Barchiesi, Giacomo Rughetti, Aurelia Bellati, Filippo Benedetti-Panici, Pierluigi Nuti, Marianna |
| author_facet | Napoletano, Chiara Visconti, Valeria Antonilli, Morena Zizzari, Ilaria G Rahimi, Hassan Battisti, Federico Caponnetto, Salvatore Barchiesi, Giacomo Rughetti, Aurelia Bellati, Filippo Benedetti-Panici, Pierluigi Nuti, Marianna |
| author_sort | Napoletano, Chiara |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3991372 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-39913722014-05-05 Preliminary results of a triple peptide escalating dose vaccination phase I/II clinical trial as consolidation treatment in women affected by ovarian cancer Napoletano, Chiara Visconti, Valeria Antonilli, Morena Zizzari, Ilaria G Rahimi, Hassan Battisti, Federico Caponnetto, Salvatore Barchiesi, Giacomo Rughetti, Aurelia Bellati, Filippo Benedetti-Panici, Pierluigi Nuti, Marianna J Immunother Cancer Poster Presentation BioMed Central 2013-11-07 /pmc/articles/PMC3991372/ http://dx.doi.org/10.1186/2051-1426-1-S1-P227 Text en Copyright © 2013 Napoletano et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Poster Presentation Napoletano, Chiara Visconti, Valeria Antonilli, Morena Zizzari, Ilaria G Rahimi, Hassan Battisti, Federico Caponnetto, Salvatore Barchiesi, Giacomo Rughetti, Aurelia Bellati, Filippo Benedetti-Panici, Pierluigi Nuti, Marianna Preliminary results of a triple peptide escalating dose vaccination phase I/II clinical trial as consolidation treatment in women affected by ovarian cancer |
| title | Preliminary results of a triple peptide escalating dose vaccination phase I/II clinical trial as consolidation treatment in women affected by ovarian cancer |
| title_full | Preliminary results of a triple peptide escalating dose vaccination phase I/II clinical trial as consolidation treatment in women affected by ovarian cancer |
| title_fullStr | Preliminary results of a triple peptide escalating dose vaccination phase I/II clinical trial as consolidation treatment in women affected by ovarian cancer |
| title_full_unstemmed | Preliminary results of a triple peptide escalating dose vaccination phase I/II clinical trial as consolidation treatment in women affected by ovarian cancer |
| title_short | Preliminary results of a triple peptide escalating dose vaccination phase I/II clinical trial as consolidation treatment in women affected by ovarian cancer |
| title_sort | preliminary results of a triple peptide escalating dose vaccination phase i/ii clinical trial as consolidation treatment in women affected by ovarian cancer |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991372/ http://dx.doi.org/10.1186/2051-1426-1-S1-P227 |
| work_keys_str_mv | AT napoletanochiara preliminaryresultsofatriplepeptideescalatingdosevaccinationphaseiiiclinicaltrialasconsolidationtreatmentinwomenaffectedbyovariancancer AT viscontivaleria preliminaryresultsofatriplepeptideescalatingdosevaccinationphaseiiiclinicaltrialasconsolidationtreatmentinwomenaffectedbyovariancancer AT antonillimorena preliminaryresultsofatriplepeptideescalatingdosevaccinationphaseiiiclinicaltrialasconsolidationtreatmentinwomenaffectedbyovariancancer AT zizzariilariag preliminaryresultsofatriplepeptideescalatingdosevaccinationphaseiiiclinicaltrialasconsolidationtreatmentinwomenaffectedbyovariancancer AT rahimihassan preliminaryresultsofatriplepeptideescalatingdosevaccinationphaseiiiclinicaltrialasconsolidationtreatmentinwomenaffectedbyovariancancer AT battistifederico preliminaryresultsofatriplepeptideescalatingdosevaccinationphaseiiiclinicaltrialasconsolidationtreatmentinwomenaffectedbyovariancancer AT caponnettosalvatore preliminaryresultsofatriplepeptideescalatingdosevaccinationphaseiiiclinicaltrialasconsolidationtreatmentinwomenaffectedbyovariancancer AT barchiesigiacomo preliminaryresultsofatriplepeptideescalatingdosevaccinationphaseiiiclinicaltrialasconsolidationtreatmentinwomenaffectedbyovariancancer AT rughettiaurelia preliminaryresultsofatriplepeptideescalatingdosevaccinationphaseiiiclinicaltrialasconsolidationtreatmentinwomenaffectedbyovariancancer AT bellatifilippo preliminaryresultsofatriplepeptideescalatingdosevaccinationphaseiiiclinicaltrialasconsolidationtreatmentinwomenaffectedbyovariancancer AT benedettipanicipierluigi preliminaryresultsofatriplepeptideescalatingdosevaccinationphaseiiiclinicaltrialasconsolidationtreatmentinwomenaffectedbyovariancancer AT nutimarianna preliminaryresultsofatriplepeptideescalatingdosevaccinationphaseiiiclinicaltrialasconsolidationtreatmentinwomenaffectedbyovariancancer |